rs1555908409
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_002872.5(RAC2):c.184G>A(p.Glu62Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002872.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAC2 | NM_002872.5 | c.184G>A | p.Glu62Lys | missense_variant | 3/7 | ENST00000249071.11 | NP_002863.1 | |
RAC2 | XM_006724286.4 | c.184G>A | p.Glu62Lys | missense_variant | 3/6 | XP_006724349.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAC2 | ENST00000249071.11 | c.184G>A | p.Glu62Lys | missense_variant | 3/7 | 1 | NM_002872.5 | ENSP00000249071.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461808Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727202
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neutrophil immunodeficiency syndrome;C5436549:Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia;C5436550:Immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Nov 23, 2021 | RAC2:NM_002872:exon3, p.Glu62Lys (c.184G>A): This variant has been reported in 1 individual with suspected Combined Immune Deficiency (CID) as de novo (Hsu 2016) and is not present in large control databases. Furthermore, it is a de novo variant in this child, and evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is highly suspicious for disease, but requires further evidence for pathogenicity. Therefore, this variant classified as likely pathogenic. - |
Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 24, 2020 | - - |
Immunodeficiency;C0024312:Lymphopenia;C0085110:Severe combined immunodeficiency disease;C2711630:Combined immunodeficiency;C4023166:Abnormality of T cell physiology;C4023612:Abnormal cellular immune system morphology Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Personalized Medicine, Children's Hospital Los Angeles | - | - - |
Neutrophil immunodeficiency syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 31, 2022 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects RAC2 function (PMID: 30723080). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RAC2 protein function. ClinVar contains an entry for this variant (Variation ID: 464885). This missense change has been observed in individual(s) with autosomal dominant combined immunodeficiency (PMID: 30723080; Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 62 of the RAC2 protein (p.Glu62Lys). - |
See cases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Personalized Medicine, Children's Hospital Los Angeles | Dec 21, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2023 | RAC2: PS2:Very Strong, PM2, PS4:Moderate, PP3, PS3:Supporting - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at